Format

Send to

Choose Destination
PLoS One. 2014 Jun 2;9(6):e98169. doi: 10.1371/journal.pone.0098169. eCollection 2014.

Immunohistochemical and molecular characteristics with prognostic significance in diffuse large B-cell lymphoma.

Author information

1
Laboratory of Molecular Pathology, Instituto de Investigación Sanitaria, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.
2
Unidad de Bioestadística Clínica, Hospital Universitario Ramón y Cajal, CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
3
Department of Hematology, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.
4
Medical Oncology Service, Onco-hematology Research Unit, Instituto de Investigación Sanitaria, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.

Abstract

Diffuse large B-cell lymphoma (DLBCL) is an aggressive non-Hodgkin lymphoma with marked biologic heterogeneity. We analyzed 100 cases of DLBCL to evaluate the prognostic value of immunohistochemical markers derived from the gene expression profiling-defined cell origin signature, including MYC, BCL2, BCL6, and FOXP1 protein expression. We also investigated genetic alterations in BCL2, BCL6, MYC and FOXP1 using fluorescence in situ hybridization and assessed their prognostic significance. BCL6 rearrangements were detected in 29% of cases, and BCL6 gene alteration (rearrangement and/or amplification) was associated with the non-germinal center B subtype (non-GCB). BCL2 translocation was associated with the GCB phenotype, and BCL2 protein expression was associated with the translocation and/or amplification of 18q21. MYC rearrangements were detected in 15% of cases, and MYC protein expression was observed in 29% of cases. FOXP1 expression, mainly of the non-GCB subtype, was demonstrated in 37% of cases. Co-expression of the MYC and BCL2 proteins, with non-GCB subtype predominance, was observed in 21% of cases. We detected an association between high FOXP1 expression and a high proliferation rate as well as a significant positive correlation between MYC overexpression and FOXP1 overexpression. MYC, BCL2 and FOXP1 expression were significant predictors of overall survival. The co-expression of MYC and BCL2 confers a poorer clinical outcome than MYC or BCL2 expression alone, whereas cases negative for both markers had the best outcomes. Our study confirms that DLBCL, characterized by the co-expression of MYC and BCL2 proteins, has a poor prognosis and establishes a significant positive correlation with MYC and FOXP1 over-expression in this entity.

PMID:
24887414
PMCID:
PMC4041883
DOI:
10.1371/journal.pone.0098169
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Public Library of Science Icon for PubMed Central
Loading ...
Support Center